Annual Net Income
$35.64 M
+$44.27 M+513.14%
31 December 2022
Summary:
Eagle Pharmaceuticals annual net profit is currently $35.64 million, with the most recent change of +$44.27 million (+513.14%) on 31 December 2022. During the last 3 years, it has risen by +$23.65 million (+197.29%). EGRX annual net income is now -56.24% below its all-time high of $81.45 million, reached on 31 December 2016.EGRX Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
$5.16 M
-$586.00 K-10.19%
30 June 2023
Summary:
Eagle Pharmaceuticals quarterly net profit is currently $5.16 million, with the most recent change of -$586.00 thousand (-10.19%) on 30 June 2023. EGRX quarterly net income is now -90.99% below its all-time high of $57.30 million, reached on 31 December 2016.EGRX Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
$11.95 M
+$14.61 M+548.16%
30 June 2023
Summary:
Eagle Pharmaceuticals TTM net profit is currently $11.95 million, with the most recent change of +$14.61 million (+548.16%) on 30 June 2023. EGRX TTM net income is now -88.65% below its all-time high of $105.28 million, reached on 31 March 2017.EGRX TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EGRX Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | +197.3% | +191.8% | +112.4% |
| 5 y5 years | +11.7% | +316.1% | -53.9% |
EGRX Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +513.1% | -88.3% | +154.7% | -66.7% | +238.5% |
| 5 y | 5 years | at high | +513.1% | -88.3% | +154.7% | -66.7% | +238.5% |
| alltime | all time | -56.2% | +283.9% | -91.0% | +150.8% | -88.7% | +159.1% |
Eagle Pharmaceuticals Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | $5.16 M(-10.2%) | $11.95 M(-548.2%) |
| Mar 2023 | - | $5.75 M(-29.6%) | -$2.67 M(-107.5%) |
| Dec 2022 | $35.64 M(-513.1%) | $8.16 M(-214.5%) | $35.64 M(+67.5%) |
| Sept 2022 | - | -$7.13 M(-24.5%) | $21.28 M(-6.6%) |
| June 2022 | - | -$9.45 M(-121.4%) | $22.79 M(-36.4%) |
| Mar 2022 | - | $44.06 M(-811.1%) | $35.85 M(-515.6%) |
| Dec 2021 | -$8.63 M(-172.0%) | -$6.20 M(+10.2%) | -$8.63 M(-253.3%) |
| Sept 2021 | - | -$5.62 M(-255.6%) | $5.63 M(-69.3%) |
| June 2021 | - | $3.61 M(-958.0%) | $18.31 M(+26.8%) |
| Mar 2021 | - | -$421.00 K(-105.2%) | $14.44 M(+20.4%) |
| Dec 2020 | $11.99 M(-16.2%) | $8.06 M(+14.1%) | $11.99 M(+142.8%) |
| Sept 2020 | - | $7.06 M(-2857.4%) | $4.94 M(-209.4%) |
| June 2020 | - | -$256.00 K(-91.1%) | -$4.51 M(-282.7%) |
| Mar 2020 | - | -$2.87 M(-385.7%) | $2.47 M(-82.7%) |
| Dec 2019 | $14.31 M(-55.1%) | $1.00 M(-142.1%) | $14.31 M(-44.7%) |
| Sept 2019 | - | -$2.39 M(-135.5%) | $25.90 M(-38.8%) |
| June 2019 | - | $6.72 M(-25.1%) | $42.33 M(+10.6%) |
| Mar 2019 | - | $8.97 M(-28.7%) | $38.26 M(+19.9%) |
| Dec 2018 | $31.90 M(-38.6%) | $12.59 M(-10.3%) | $31.91 M(+12.3%) |
| Sept 2018 | - | $14.04 M(+428.0%) | $28.40 M(-4.7%) |
| June 2018 | - | $2.66 M(+1.6%) | $29.79 M(-5.8%) |
| Mar 2018 | - | $2.62 M(-71.2%) | $31.64 M(-39.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2017 | $51.94 M(-36.2%) | $9.09 M(-41.1%) | $51.94 M(-48.1%) |
| Sept 2017 | - | $15.43 M(+242.7%) | $100.16 M(+3.6%) |
| June 2017 | - | $4.50 M(-80.4%) | $96.68 M(-8.2%) |
| Mar 2017 | - | $22.92 M(-60.0%) | $105.28 M(+29.2%) |
| Dec 2016 | $81.45 M(+3068.1%) | $57.30 M(+379.4%) | $81.46 M(+221.0%) |
| Sept 2016 | - | $11.95 M(-8.8%) | $25.37 M(+679.5%) |
| June 2016 | - | $13.10 M(-1561.9%) | $3.25 M(-118.1%) |
| Mar 2016 | - | -$896.00 K(-173.5%) | -$18.02 M(-800.7%) |
| Dec 2015 | $2.57 M(-114.3%) | $1.22 M(-112.0%) | $2.57 M(-161.9%) |
| Sept 2015 | - | -$10.17 M(+24.3%) | -$4.15 M(+34.4%) |
| June 2015 | - | -$8.18 M(-141.5%) | -$3.09 M(-243.5%) |
| Mar 2015 | - | $19.70 M(-457.7%) | $2.15 M(-110.6%) |
| Dec 2014 | - | -$5.51 M(-39.5%) | -$20.23 M(+12.5%) |
| Sept 2014 | -$17.98 M(+197.2%) | -$9.10 M(+210.3%) | -$17.98 M(+114.3%) |
| June 2014 | - | -$2.93 M(+9.3%) | -$8.39 M(+78.5%) |
| Mar 2014 | - | -$2.68 M(-17.5%) | -$4.70 M(-31.1%) |
| Dec 2013 | - | -$3.25 M(-772.8%) | -$6.82 M(+12.8%) |
| Sept 2013 | -$6.05 M(-68.8%) | $483.80 K(-35.9%) | -$6.05 M(-7.4%) |
| June 2013 | - | $754.60 K(-115.7%) | -$6.53 M(-10.4%) |
| Mar 2013 | - | -$4.80 M(+93.5%) | -$7.29 M(+193.5%) |
| Dec 2012 | - | -$2.48 M | -$2.48 M |
| Sept 2012 | -$19.38 M | - | - |
FAQ
- What is Eagle Pharmaceuticals annual net profit?
- What is the all time high annual net income for Eagle Pharmaceuticals?
- What is Eagle Pharmaceuticals quarterly net profit?
- What is the all time high quarterly net income for Eagle Pharmaceuticals?
- What is Eagle Pharmaceuticals TTM net profit?
- What is the all time high TTM net income for Eagle Pharmaceuticals?
What is Eagle Pharmaceuticals annual net profit?
The current annual net income of EGRX is $35.64 M
What is the all time high annual net income for Eagle Pharmaceuticals?
Eagle Pharmaceuticals all-time high annual net profit is $81.45 M
What is Eagle Pharmaceuticals quarterly net profit?
The current quarterly net income of EGRX is $5.16 M
What is the all time high quarterly net income for Eagle Pharmaceuticals?
Eagle Pharmaceuticals all-time high quarterly net profit is $57.30 M
What is Eagle Pharmaceuticals TTM net profit?
The current TTM net income of EGRX is $11.95 M
What is the all time high TTM net income for Eagle Pharmaceuticals?
Eagle Pharmaceuticals all-time high TTM net profit is $105.28 M